Zinc and platelet membrane microviscosity in Alzheimer's disease. The in vivo effect of zinc on platelet membranes and cognition. 1997

F C Potocnik, and S J van Rensburg, and C Park, and J J Taljaard, and R A Emsley
Department of Psychiatry, University of Stellenbosch, Tygerberg, W Cape.

OBJECTIVE To investigate the effects of oral zinc supplementation on: (i) plasma zinc concentrations; (ii) platelet membrane microviscosity in vivo; and (iii) cognitive function of Alzheimer's disease (AD) patients. METHODS An open-labelled pilot study. METHODS University of Stellenbosch Medical School and Stikland Hospital. METHODS Six volunteer AD patients. METHODS Plasma zinc levels, platelet membrane microviscosity and cognition (MMSE and ADAS-cog tests). RESULTS Oral zinc supplementation (30 mg/day) did not increase plasma zinc levels significantly, but significantly increased platelet membrane microviscosity (P = 0.02; 6 patients). Four patients, who underwent 12 months of evaluation, showed modest cognitive improvement on psychometric testing (Mini-Mental State Examination and the cognitive portion of the Alzheimer's Disease Assessment scale scores). CONCLUSIONS While earlier literature promoted the use of zinc in AD patients, a recent study has contradicted this and implicated zinc in the aetiology of Alzheimer's disease. On the basis of the above results, it may be premature to single out zinc as a causal agent in AD.

UI MeSH Term Description Entries
D008297 Male Males
D008560 Membrane Fluidity The motion of phospholipid molecules within the lipid bilayer, dependent on the classes of phospholipids present, their fatty acid composition and degree of unsaturation of the acyl chains, the cholesterol concentration, and temperature. Bilayer Fluidity,Bilayer Fluidities,Fluidities, Bilayer,Fluidities, Membrane,Fluidity, Bilayer,Fluidity, Membrane,Membrane Fluidities
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia

Related Publications

F C Potocnik, and S J van Rensburg, and C Park, and J J Taljaard, and R A Emsley
November 1976, Biochemistry,
F C Potocnik, and S J van Rensburg, and C Park, and J J Taljaard, and R A Emsley
January 1984, Psychopharmacology,
F C Potocnik, and S J van Rensburg, and C Park, and J J Taljaard, and R A Emsley
March 1991, Clinical science (London, England : 1979),
F C Potocnik, and S J van Rensburg, and C Park, and J J Taljaard, and R A Emsley
January 1996, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine,
F C Potocnik, and S J van Rensburg, and C Park, and J J Taljaard, and R A Emsley
March 1994, American journal of hypertension,
F C Potocnik, and S J van Rensburg, and C Park, and J J Taljaard, and R A Emsley
August 1987, Annals of neurology,
F C Potocnik, and S J van Rensburg, and C Park, and J J Taljaard, and R A Emsley
January 2012, BioFactors (Oxford, England),
F C Potocnik, and S J van Rensburg, and C Park, and J J Taljaard, and R A Emsley
January 1989, Biofizika,
F C Potocnik, and S J van Rensburg, and C Park, and J J Taljaard, and R A Emsley
June 1990, Biochimica et biophysica acta,
F C Potocnik, and S J van Rensburg, and C Park, and J J Taljaard, and R A Emsley
January 1994, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
Copied contents to your clipboard!